159 related articles for article (PubMed ID: 35434945)
1. Anti-hyperglycemic effect of Abelmoschus culentesus (Okra) on patients with diabetes type 2: a randomized clinical trial.
Saatchi A; Aghamohammadzadeh N; Beheshtirouy S; Javadzadeh Y; Afshar FH; Ghaffary S
Phytother Res; 2022 Apr; 36(4):1644-1651. PubMed ID: 35434945
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial.
Tavakolizadeh M; Peyrovi S; Ghasemi-Moghaddam H; Bahadori A; Mohkami Z; Sotoudeh M; Ziaee M
Acta Diabetol; 2023 Dec; 60(12):1685-1695. PubMed ID: 37507536
[TBL] [Abstract][Full Text] [Related]
3. Effects of okra (Abelmoschus esculentus (L.) Moench) on glycemic markers in animal models of diabetes: A systematic review.
Sereno AB; Dayane Pinto C; Antunes Andrade F; Aparecida Bertolazo da Silva M; Carvalho Garcia A; Carneiro Hecke Krüger C; José de Messias Reason I
J Ethnopharmacol; 2022 Nov; 298():115544. PubMed ID: 35963420
[TBL] [Abstract][Full Text] [Related]
4. Superiority of Purple Okra (
Tyagita N; Mahati E; Safitri AH
Folia Med (Plovdiv); 2021 Feb; 63(1):51-58. PubMed ID: 33650396
[TBL] [Abstract][Full Text] [Related]
5. Abelmoschus esculentus (L.) Moench improved blood glucose, lipid, and down-regulated PPAR-α, PTP1B genes expression in diabetic rats.
Nasrollahi Z; ShahaniPour K; Monajemi R; Ahadi AM
J Food Biochem; 2022 Jul; 46(7):e14097. PubMed ID: 35102562
[TBL] [Abstract][Full Text] [Related]
6. Effect of Abelmoschus esculentus (okra) on metabolic syndrome: A review.
Esmaeilzadeh D; Razavi BM; Hosseinzadeh H
Phytother Res; 2020 Sep; 34(9):2192-2202. PubMed ID: 32222004
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive study to evaluate the wound healing potential of okra (Abelmoschus esculentus) fruit.
Sipahi H; Orak D; Reis R; Yalman K; Şenol O; Palabiyik-Yücelik SS; Deniz İ; Algül D; Guzelmeric E; Çelep ME; Argin S; Özkan F; Halıcı Z; Aydın A; Yesilada E
J Ethnopharmacol; 2022 Apr; 287():114843. PubMed ID: 34801610
[TBL] [Abstract][Full Text] [Related]
8. The effect of okra (Abelmoschus esculentus) on lipid profiles and glycemic indices in Type 2 diabetic adults: Randomized double blinded trials.
Moradi A; Tarrahi MJ; Ghasempour S; Shafiepour M; Clark CCT; Safavi SM
Phytother Res; 2020 Dec; 34(12):3325-3332. PubMed ID: 32706159
[TBL] [Abstract][Full Text] [Related]
9. Abscisic acid identification in Okra,
Daliu P; Annunziata G; Tenore GC; Santini A
Nat Prod Res; 2020 Jan; 34(1):3-9. PubMed ID: 31282220
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Abelmoschus Esculentus on Blood Levels of Glucose in Diabetes Mellitus.
Khosrozadeh M; Heydari N; Abootalebi M
Iran J Med Sci; 2016 May; 41(3 Suppl):S63. PubMed ID: 27840529
[TBL] [Abstract][Full Text] [Related]
11. Polysaccharide from Okra (
Liao Z; Zhang J; Liu B; Yan T; Xu F; Xiao F; Wu B; Bi K; Jia Y
Molecules; 2019 May; 24(10):. PubMed ID: 31108940
[TBL] [Abstract][Full Text] [Related]
12. A blend of Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit extracts relieves constipation and improves bowel function: A proof-of-concept clinical investigation.
Punukollu RS; Chadalawada AK; Siddabattuni K; Gogineni NT
J Ethnopharmacol; 2024 Jan; 318(Pt B):116997. PubMed ID: 37543151
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Abelmoschus esculentus Against Alloxan-induced Diabetes in Wistar Strain Rats.
Mishra N; Kumar D; Rizvi SI
J Diet Suppl; 2016 Nov; 13(6):634-46. PubMed ID: 27065051
[TBL] [Abstract][Full Text] [Related]
14. Biological activity and development of functional foods fortified with okra (
Agregán R; Pateiro M; Bohrer BM; Shariati MA; Nawaz A; Gohari G; Lorenzo JM
Crit Rev Food Sci Nutr; 2023; 63(23):6018-6033. PubMed ID: 35037792
[TBL] [Abstract][Full Text] [Related]
15. In vivo anti-ulcerogenic effect of okra (Abelmoschus esculentus) on ethanol-induced acute gastric mucosal lesions.
Ortaç D; Cemek M; Karaca T; Büyükokuroğlu ME; Özdemir ZÖ; Kocaman AT; Göneş S
Pharm Biol; 2018 Dec; 56(1):165-175. PubMed ID: 29513129
[TBL] [Abstract][Full Text] [Related]
16. Okra [
Alblihd MA; Alsharif KF; Hamad AA; Ali FAZ; Hussein MT; Alhegaili AS; Hassan MA; Al-Amer OM; Albezrah NKA; Almalki AA; Albarakati AJA; Alghamdi KS; Alzahrani KJ; Albrakati A; Alrubai EH; ElAshmouny N; Elmahallawy EK
Front Vet Sci; 2023; 10():1268968. PubMed ID: 38046568
[TBL] [Abstract][Full Text] [Related]
17. Abelmoschus esculentus (L.): Bioactive Components' Beneficial Properties-Focused on Antidiabetic Role-For Sustainable Health Applications.
Durazzo A; Lucarini M; Novellino E; Souto EB; Daliu P; Santini A
Molecules; 2018 Dec; 24(1):. PubMed ID: 30583476
[TBL] [Abstract][Full Text] [Related]
18. Okra (
Elkhalifa AEO; Alshammari E; Adnan M; Alcantara JC; Awadelkareem AM; Eltoum NE; Mehmood K; Panda BP; Ashraf SA
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525745
[TBL] [Abstract][Full Text] [Related]
19. Okra (Abelmoscus esculentus) Improved Islets Structure, and Down-Regulated PPARs Gene Expression in Pancreas of High-Fat Diet and Streptozotocin-Induced Diabetic Rats.
Erfani Majd N; Tabandeh MR; Shahriari A; Soleimani Z
Cell J; 2018 Apr; 20(1):31-40. PubMed ID: 29308616
[TBL] [Abstract][Full Text] [Related]
20. The effect of Abelmoschus esculentus L. (Okra) extract supplementation on glycaemic control, inflammation, kidney function and expression of PPAR-
Nikpayam O; Saghafi-Asl M; Safaei E; Bahreyni N; Sadra V; Asgharian P
Br J Nutr; 2024 Feb; 131(4):648-657. PubMed ID: 37840235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]